Surgical Innovations Group PLC
LSE:SUN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Surgical Innovations Group PLC
Cash & Cash Equivalents
Surgical Innovations Group PLC
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Surgical Innovations Group PLC
LSE:SUN
|
Cash & Cash Equivalents
£813k
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-2%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash & Cash Equivalents
$557m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash & Cash Equivalents
$635.6m
|
CAGR 3-Years
44%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash & Cash Equivalents
£15.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
23%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash & Cash Equivalents
£8.7m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Cash & Cash Equivalents
£620k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-11%
|
|
Surgical Innovations Group PLC
Glance View
Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. The Group sells branded products through its Elemental Healthcare Ltd. (Distribution) and independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The firm operates through three segments: SI Brand, OEM and Distribution. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. Its Distribution segment is engaged in the distribution of specialist medical products sold through its Elemental Healthcare Ltd.
See Also
What is Surgical Innovations Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
813k
GBP
Based on the financial report for Dec 31, 2025, Surgical Innovations Group PLC's Cash & Cash Equivalents amounts to 813k GBP.
What is Surgical Innovations Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-2%
Over the last year, the Cash & Cash Equivalents growth was 317%. The average annual Cash & Cash Equivalents growth rates for Surgical Innovations Group PLC have been -28% over the past three years , -31% over the past five years , and -2% over the past ten years .
